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Abstract
Background: The evidence evaluating the benefits of programmatic nutrition interventions to HIV-infected individuals 
in developing countries, where there is a large overlap between HIV prevalence and malnutrition, is limited. This study 
evaluates the impact of food assistance (FA) on change in weight and disease progression as measured by WHO 
staging.
Methods: We utilize program data from The AIDS Support Organization (TASO) in Uganda to compare outcomes 
among FA recipients to a control group, using propensity score matching (PSM) methods among 14,481 HIV-infected 
TASO clients.
Results: FA resulted in a significant mean weight gain of 0.36 kg over one year period. This impact was conditional on 
anti-retroviral therapy (ART) receipt and disease stage at baseline. FA resulted in mean weight gain of 0.36 kg among 
individuals not receiving ART compared to their matched controls. HIV-infected individuals receiving FA with baseline 
WHO stage II and III had a significant weight gain (0.26 kg and 0.2 kg respectively) compared to their matched controls. 
Individuals with the most advanced disease at baseline (WHO stage IV) had the highest weight gain of 1.9 kg. The 
impact on disease progression was minimal. Individuals receiving FA were 2 percentage points less likely to progress by 
one or more WHO stage compared to their matched controls. There were no significant impacts on either outcome 
among individuals receiving ART.
Conclusions: Given the widespread overlap of HIV and malnutrition in sub-Saharan Africa, FA programs have the 
potential to improve weight and delay disease progression, especially among HIV-infected individuals not yet on ART. 
Additional well designed prospective studies evaluating the impact of FA are urgently needed.
Background
The interactions between food insecurity, malnutrition,
and HIV/AIDS are well established [1,2]. Earlier studies
from developed and developing countries consistently
show that malnutrition, as assessed by low body mass
index (BMI) or mid-upper arm circumference (MUAC),
is a strong independent predictor of mortality among
people living with HIV (PLHIV) [3-6]. Indeed, despite
increasing access to anti-retroviral therapy (ART) in
resource limited settings, recent evidence has emerged
establishing preexisting malnutrition as an independent
risk factor of mortality among patients initiating ART [7-
9]. Combined, this evidence has resulted in increased
funding to HIV care and treatment providers to provide
nutrition support to adults and children with HIV, espe-
cially those who are malnourished or have advanced HIV
disease. The hypothesized benefits of providing nutrition
support to HIV-infected individuals include: i) improved
nutritional status, ii) improved health status, iii) slowed
disease progression, iv) improved food security, v)
improved quality of life, and vi) improved ART adherence
and probability of survival.
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The evidence base evaluating the benefits of nutrition
interventions in developing countries, where there is a
large overlap between HIV prevalence and malnutrition
is limited to efficacy studies of micronutrient supplemen-
tation and more recently, specialized ready-to-use foods.
The benefits of food assistance (FA) programs, which
remain the most widespread form of nutrition support to
HIV-infected individuals in sub-Saharan Africa, are
mostly speculative and have not been rigorously evalu-
ated.
Two recent reviews on the effect of macronutrient sup-
plementation (with or without nutritional counseling) on
various clinical outcomes of people living with HIV offer
inconclusive evidence of the impact on weight gain or
CD4 count in developed countries [10,11]. Of the studies
reviewed, only two studies were available from resource
constrained settings with the bulk of evidence provided
by nine small clinical trials, all of them in the United
States or Europe, where the preexisting nutrition status of
people living with HIV is far superior to those in the
developing countries.
A challenge to generating rigorous evidence of the
impact FA programs on PLHIVs in countries where there
is widespread co-existence of malnutrition, food insecu-
rity, and HIV is the important ethical considerations in
conducting experimental studies with randomized con-
trol groups that receive no intervention. However, data
from program settings is often available, and if rigorous
methodologies are applied, this data can be utilized to
build a plausibility argument of the potential impact of
FA programs.
We capitalize on the availability of routine program
data from The AIDS Support Organization (TASO), the
largest indigenous HIV care and treatment service pro-
vider in Uganda serving over 190,000 clients since its
inception, to evaluate the effectiveness of FA provided (by
WFP and USAID in the form of a monthly household
food basket) to HIV-infected TASO clients on weight
gain, and advancement in WHO disease stage. Given the
absence of a randomized control group in this program
setting, we compared HIV-positive individuals who
received FA with a matched control group with similar
observed characteristics, using propensity score match-
ing (PSM).
During the years 2002-7, TASO clients were provided
two different types of household food rations. Based on
geographic targeting of the food distributor and house-
hold size (with a upper household size limit of 6), TASO
clients were provided either a: 1) household food ration
by the World Food Programme (WFP) comprising corn
soy blended flour, vegetable oil, pulses and maize meal or
rice, or 2) a household food ration by USAID comprising
corn soy blended flour and vegetable oil. Food rations
were distributed monthly, barring any pipeline break-
downs. These household rations and their mode of deliv-
ery represent standard food commodities and a
distribution model provided to households as part of
food aid programs throughout sub-Saharan Africa. TASO
clients were provided food assistance for varying periods
of 12-24 months based on resources, but we restricted
our analysis to available client record information closest
to the 12-month mark.
Methods
Data
The data set utilized in this analysis builds upon TASO's
electronic monitoring data system. This information sys-
tem includes computerized information from the
patient's intake registration form, medical visit summa-
ries, counseling visit summaries, as well as information
on ART initiation and other drug use. We conducted a
secondary data analysis of the records, and we analyzed
patient information for the time period 2002-2007. For
each TASO client, we retrieved all of their medical and
counseling visit files as well as their registration intake
survey information. This permitted the analysis to con-
sider social and economic information such as occupa-
tion and educational attainment, essential for PSM, along
with health information including WHO staging and
weight.
The study question of this paper focuses on changes
over 12 months for patients and how the receipt of FA
affects health outcomes measured in terms of change in
WHO staging and weight of patients receiving TASO
care and treatment services. Thus, from the patient data-
base, we pulled patient records from the first medical
visit and obtained baseline weight and WHO staging
information. Then we searched the database and pulled
the record closest to 365 days after the first medical visit.
We dropped patients with no recorded visit in the time
period of between 160 days and 560 days from the first
visit from the analysis.
The TASO data we utilize is generated through the pro-
gram's management information system (a paper system
of charts and records) and then transferred to a set of
electronic databases. By the end of 2007, TASO had regis-
tered 195,676 program participants, from 10 TASO clinic
sites across Uganda. Data cleaning involved dropping
patients with incomplete identification numbers (neces-
sary to link across the patient records databases) or those
with no program involvement in the 2002-2007 time
period. Additionally, patients were dropped if they did
not have a clinic visit in the 160 to 560 day window, or if
they had missing weight or WHO staging information.
The final number of complete observations with the nec-
essary weight and WHO records were 14, 481.
There are unique challenges to using data from pro-
gram settings. In the case of the TASO program database,
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there are three main challenges. First, as seen above, not
all TASO clients have information recorded consistently
in the TASO database system, a pervasive challenge
among large AIDS care and treatment providers in gen-
eral. Second, the available data is limited to variables that
are collected for purposes of program monitoring, and do
not include a full array of variables that would ordinarily
be collected for research purposes. Third, receipt of FA is
not random, and may correlate with several confounding
characteristics which themselves could influence the out-
comes of interest. FA eligibility in TASO's program is
determined by a poverty assessment tool, which includes
several socio-economic criteria. The main methodologi-
cal challenge to the non-random receipt of FA is that fail-
ure to control for this characteristic may generate biased
results of the impact of FA on the outcomes of interest.
The key question of interest therefore is determining how
HIV-infected individuals receiving FA would have fared
had they not received food. This paper seeks to provide
insight into this research question using propensity score
matching (PSM) techniques.
The poverty assessment tool to determine food assis-
tance eligibility from WFP covers the following domains:
household composition, ownership of valuable assets,
employment status and income, housing characteristics,
experience of food insecurity, and access to certain ser-
vices. The poverty assessment tool to determine food
assistance eligibility for USAD Title II food aid is less
comprehensive. It elicits descriptive information on
household assets, household composition (mainly num-
ber of dependents), adequacy of income to meet basic
needs and experience of food insecurity. The tools were
administered to TASO clients and scored to determine
eligibility to food assistance.
In addition to the differing tools, during the study
period of five years (2002-7), the cut-off score to deter-
mine eligibility varied, based in part on the availability of
program resources in different geographic locations
where food assistance programs operated. Since food aid
programming in the context of HIV was relatively new at
the beginning of the decade, the tools were also revised.
Because of these variations in the tools and in determin-
ing eligibility across TASO program sites, relying on the
poverty assessment tool alone would have provided erro-
neous impact estimates.
We matched individuals using propensity score match-
ing methods, using more detailed responses to the
domains captured in the poverty assessment tool as well
as additional variables not captured in the poverty assess-
ment tool. These variables were captured from patient
records that are part of the TASO intake registry. This
allows for a more robust matching technique that goes
beyond the limited set of variables and response options
in the poverty assessment tool.
Propensity Score Matching
We estimated the impact of food assistance using pro-
pensity score matching with difference-in-difference
(DID) estimates. This statistical procedure compares the
change over time in the outcomes of interest for food
assistance TASO clients with the change over time to
matched comparison TASO clients.
To understand the true effect of FA, we need to esti-
mate a) the outcomes of interest among those receiving
FA and b) the outcomes of interest on the same individual
under the same conditions, but without receipt of FA.
Since the latter is unobservable, we need to construct a
proxy counterfactual for the missing data. In order to do
this, information on each FA recipient is matched to a
sample of similar non-FA recipients for the same two
periods [12]. PSM allows us to match each FA recipient
with similar non-FA recipients, and use the outcome of
the non-FA recipients as a proxy for the outcome of the
FA recipients if they had not received FA [13].
There may be something about FA recipients that
makes them different from the general set of households.
For example, if an individual with a higher number of
dependents is more likely to receive FA, we would want
to consider the number of dependents when matching
individuals. Thus, matching entails identifying a set of
characteristics that are associated with an increased pro-
pensity to receive FA and likely to influence the outcome
[14].
PSM involves two steps. First, obtaining propensity
scores involves estimating a probit or a logit model that
predicts the probability of each PLHIV receiving FA as a
function of baseline characteristics using the sample of
FA recipients and non-recipients. Second, for each FA
recipient, matching involves finding a non- FA recipient
with the closest estimated propensity score. The match-
ing estimator was implemented using kernel matching.
This study estimates the effect of FA on outcomes on
FA recipients. This is known in the literature as the "aver-
age treatment effect on the treated" (ATT). The ATT is
obtained by comparing the change in means of the out-
come of interest between the matched FA and non-FA
recipient. It is plausible that unobservable characteristics
that are uncorrelated to observables may still bias the
impact estimations after PSM. In order to further
improve the impact estimations, we employ difference-
in-difference (DID) estimation. DID is the pre and post
difference between treatment and control groups. DID
estimates are known to be less subject to selection bias
because they remove the effect of any unobserved time-
invariant differences between the treatment and compar-
ison groups [15]. We estimated the overall and condi-
tional effects of FA on changes in weight and disease
progression by one or more WHO stages.
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Variable Description
The main treatment variable is receipt of FA in the form
of a household food basket ration. The primary outcome
variables of interest are: a) change in weight in kilograms,
and b) advancement in WHO disease staging by one or
more stages. We estimated a logit to compute the pro-
pensity score. The log odds of receiving FA was estimated
by a set of independent variables at baseline including
sex, age, number of dependents, education, religion,
occupation, marital status, time in days from the initial
visit to the visit closest to one year from the initial visit,
and distance to a TASO medical center. We further
included a set of TASO site dummy variables to control
for community level characteristics.
Ethical Review
The ethics review boards of TASO, the Uganda National
Council on Science and Technology (UNCST) and IFPRI
approved the study protocol.
Results
Descriptive Statistics
Our final sample for analysis included 14, 481 observa-
tions, twenty-three percent of whom reported receiving
food assistance (Table 1). Included in this table are
descriptive characteristics of select variables of interest.
Here, we discern some significant differences in baseline
characteristics of FA recipients and non-recipients. The
overall mean weight gain over a period of one year in this
population was 0.95 kg; FA recipients had a mean weight
gain of 1.2 kg, compared to a mean weight gain of 0.85 kg
among non-recipients. Overall, 24% of the cohort experi-
enced disease progression by one or more WHO stages;
this was slightly higher among non-FA recipients (25%)
compared to FA recipients (23%). These changes in our
outcomes of interest over a period of one year are raw
values, not based on PSM methods.
Propensity Score Matching Results
After estimating the propensity score, we generated a
sample of matched FA recipients and non- FA recipients.
FA recipients with an estimated propensity score above
the maximum or below the minimum propensity score
for the comparison group were treated as not having
''common support" in the comparison group and so were
dropped from the matched sample [12,16]. Figure 1
shows the kernel density plots of the estimated propen-
sity scores before and after matching. Here, we observe
negligible difference in the mean propensity scores and
their distribution of the two groups after kernel match-
ing, indicating that we were successful in our matching.
Impact of Food Assistance on Weight Gain
Overall, we observe that FA resulted in a statistically sig-
nificant mean weight gain of 0.36 kg over the one year
period (Table 2). The disaggregated analyses show that
the impact of FA was conditional on both the receipt of
ART, and baseline HIV disease status as measured by
WHO stage. FA resulted in a statistically significant
Table 1: Baseline characteristics TASO clients receiving and not 
receiving food assistance
Recipients of 
Food Assistance 
(n = 3370)
Non Recipients of 
Food Assistance 
(n = 11,111)
Age (yrs) 38.3 39.0
Sex (Female) 2,623 (77.8%) 7,814 (70.3%)
Receipt of ART 556 (16.5%) 1,155 (10.4%)
Baseline Weight (kgs) 53.6 53.5
Baseline WHO Status
Stage I 334 (9.9%) 1,546 (13.9%)
Stage II 2,358 (70.0%) 7,502 (67.5%)
Stage III 619 (18.4%) 1,886 (17.0%)
Stage IV 59 (1.8%) 177 (1.59%)
Education Level
Primary 1,192 (59.1%) 6,586 (59.3%)
Secondary 642 (19.1%) 1,960 (17.6%)
Other/None 736 (21.8%) 2,565 (23.1)
Marriage Status
Married/Cohabiting 1,439 (42.7%) 5,274 (47.5%)
Divorced/Separated 544 (16.1%) 1,721 (15.5%)
Never Married 96 (2.9%) 383 (3.5%)
Widowed 1,235 (36.7%) 3,448 (31.0%)
Other 56 (1.7%) 285 (2.6%)
Occupation
Casual Laborer 270 (8.0%) 826 (7.4%)
Paid Employee 157 (4.7%) 649 (5.8%)
Peasant Farmer 1,312 (38.9%) 5,529 (49.8%)
Vendor 295 (8.8%) 893 (8.0%)
Other 1,336 (39.6%) 3,214 (28.9%)
Distance to TASO Center
<10 kms 1,527 (45.3%) 2,972 (26.8%)
10-20 kms 623 (18.5%) 1,716 (15.4)
>20 kms 1,220 (36.2%) 6,423 (57.8%)
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weight gain of 0.36 kg during the one year study period
among PLHIVs not receiving ART compared with their
matched controls (individuals neither receiving FA nor
ART). PLHIVs receiving ART and FA did not have a sig-
nificant weight gain compared to their matched controls
(individuals receiving ART, but not FA). There was no
observed impact of FA among PLHIVs who were in the
early stages of HIV, as characterized by WHO stage I at
baseline (Table 2). We discern a positive and statistically
significant impact of FA among individuals with a more
advanced disease stage at baseline (WHO stage II
onwards). PLHIVs receiving FA at baseline WHO stage II
and III had a significant weight gain (0.26 kg and 0.2 kg
respectively) compared to their matched controls with
the same baseline WHO stage who did not received FA.
Those with the most advanced disease stage at baseline
(WHO stage IV, often characterized by severe wasting),
had the highest weight gain point estimate over the one
year period (1.9 kg).
Impact of Food Assistance on WHO Disease Staging
While FA significantly slowed disease progression, as
measured by advancement by one or more WHO stage
(Table 3), the effect size of this impact is minimal. Over
the course of one year, PLHIVs who received FA were two
percentage points less likely to progress by one WHO dis-
ease stage or more, compared to their matched controls.
Among those who did not receive ART, individuals who
received FA were three percentage points less likely to
worsen than their matched controls (individuals neither
receiving ART, nor FA). We found no impact of FA
among individuals who received ART.
Figure 1 Kernel density plots before and after matching.
0 
1 
2 
3 
0 .2 .4 .6 
Estimated Propensity Score
Matched Control Food assistance Recipient
Kernel Density of Propensity Scores (post-Matching) 
0 
1 
2 
3 
0 .2 .4 .6 .8 
Estimated Propensity Score
Matched Control Food assistance Recipient
Kernel Density of Propensity Scores (pre-Matching) 
Table 2: Average treatment effect (ATT) of food assistance on change in weight of people living with HIV
Change in Weight Food assistance Recipients (n) Matched Controls (n) ATTa (absolute value of t-statistic)
Overall 3329 10685 0.36 (3.46)**
Conditional estimates
Without ART 2783 9661 0.36 (2.40)*
With ART 546 1120 0.19 (0.43)
Baseline WHO stage 1 327 1479 -0.2 (0.55)
Baseline WHO stage 2 2329 7318 0.26 (2.3)*
Baseline WHO stage 3 615 1807 0.2 (1.8)+
Baseline WHO stage 4 58 129 1.9 (1.9)+
a Absolute value of t-statistics on ATT, in parentheses, are based on bootstrapped standard errors
** significant at 1% ; *significant at 5% ; + significant at 10%
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Discussion
International organizations such as the World Health
Organization (WHO), the Joint United Nations Pro-
gramme on HIV/AIDS (UNAIDS), World Food Program
(WFP), Food and Agriculture Organization (FAO) and
The United States President's Emergency Plan for AIDS
Relief (PEPFAR) have recommended integration of food
assistance into AIDS care and treatment programs
[17,18]. Several of these organizations have tailored inter-
ventions to specifically address malnutrition and food
insecurity in areas with high prevalence of HIV, particu-
larly in sub-Saharan Africa. In 2007, PEPFAR integrated
food assistance interventions as an integral part of AIDS
care and treatment services. Health care providers and
NGOs involved in HIV care and treatment are now
increasingly utilizing targeted food assistance to improve
nutritional and clinical outcome of their clientele. Despite
this growing recognition and activity in integrating tar-
geted food assistance to PLHIVs in the context of HIV,
there have been few rigorous studies to evaluate the
health and nutritional impact of these programs.
While food assistance programs to HIV affected house-
holds are widespread, studies evaluating the impact of
these programs on people living with HIV and with pre-
existing food and nutrition insecurity are just beginning
to emerge. Given the ethical and programmatic chal-
lenges of randomizing food assistance in chronically food
insecure and high HIV prevalence contexts, most studies
currently being carried out employ quasi experimental
designs with control groups or randomize participants to
two different types of food supplementation regimens. At
present, there are only 2 published studies that evaluate
the impact of macronutrient supplementation to HIV
infected individuals in a resource-constrained setting. In
a quasi-experimental study in Zambia, food supplemen-
tation was associated with better adherence to ART, after
adjustment for sex, age, and baseline CD4 count, WHO
stage, and hemoglobin [19]. In this study however, there
was no significant effect of food supplementation on
weight gain or disease progression. In a randomized con-
trolled trial from Malawi [20] comparing supplementary
feeding with a ready-to-use fortified spread compared to
corn-soy blended flour with a similar energy composi-
tion, patients receiving fortified spread had a greater
increase in BMI and fat-free body mass than those receiv-
ing corn-soy blend, but there were no significant
observed differences in markers of disease progression,
quality of life, or adherence to ART between the two
groups.
Our study contributes to the literature on understand-
ing the impact of food assistance on HIV-infected indi-
viduals. The commodities provided are the most
commonly available supplementary foods in food aid pro-
grams in sub-Saharan Africa. Using data from a large pro-
grammatic setting, we observe an overall positive impact
of food assistance on weight gain, and a minimal impact
on delaying disease progression as measured by WHO
staging. The impact on weight gain was greatest among
individuals with more the most advanced disease stage at
baseline, where we observe an increase of almost 2 kg,
which was significant at the 10% level, despite there being
very few individuals categorized as WHO Stage IV at
baseline. It is plausible that there is selective attrition of
individuals with more advanced stage, especially in the
early years in the panel when ART was not as widely
accessible. A part of the attrition in the monitoring data-
base (and not necessarily TASO services) could also be
due to the expansion of TASO's home based care and
treatment programs and consequently less attention to
entering data into monitoring databases. The observation
of a greater impact of food assistance among those with
more advanced disease at baseline is in line with our a
priori belief --advanced HIV disease is characterized by
severe weight loss and wasting, and the potential to bene-
fit is greatest among these individuals. Our results also
show that weight gain is observed among individuals with
less advanced disease, though the point estimates of
impact are lower. While the impacts of food assistance on
Table 3: Average treatment effect (ATT) of food assistance on advancement in WHO stage by one or more WHO stage
Change in HIV WHO stage Number of treated Number of matched controls ATTa (absolute value of t-statistic)
Overall 3329 10805 -0.02 (2.14)*
Conditional estimates
Without ART 2783 9661 -0.03 (3.43)**
With ART 546 1120 0.025 (0.95)
a Absolute value of t-statistics on ATT, in parentheses, are based on bootstrapped standard errors
** significant at 1% ; *significant at 5%
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disease progression are small in magnitude, these results
are important nonetheless, considering our inability to
carefully control data collection or the compliance and
follow-up of TASO clients in this large, overburdened,
real-life program setting where care and treatment ser-
vice provision are the primary goals. We contend that in a
carefully controlled study, the impacts of food assistance
would likely be significantly greater on our outcomes of
interest.
It is important to highlight that the lack of observed
impact among the subset of individuals receiving ART
should be interpreted with caution. We do not in any way
suggest, nor should it be inferred, that nutrition support
to individuals receiving ART is of no benefit. The current
consensus is clear; malnutrition and food insecurity have
emerged as major barriers to the effectiveness of ART
programs in sub-Saharan Africa. There are several factors
that deserve discussion. First, our data does not allow us
to determine when during the course of taking ART, food
assistance was provided. Ideally, we would have designed
a prospective study that allowed us to examine the impact
of food assistance immediately upon starting ART. We
have no ability to determine when ART was initiated, or
disaggregate our analysis by time on ART. Second, avail-
ability of ART was severely limited, especially in the early
part of the decade, and PLHIVs with only the most
advanced disease stage were given ART. Related to this,
we have no measure of compliance or duration of ART. It
is therefore not surprising that we do not find an impact
of food assistance on advancement of HIV by one or
more WHO stages among those on ART. Now, with the
wider availability of ART and revision of guidelines for
their initiation, prospective studies are critically needed
to understand the impact of FA among those initiating
ART. Lastly, it is possible that food assistance may have
had an impact on other important outcomes such as ART
adherence and quality of life, the study of which is beyond
the scope of this paper.
Additionally, there may be other benefits of food assis-
tance that our data was unable to examine. For example,
lack of availability of food is widely cited to be a threat to
ART adherence, but our data does not allow us to exam-
ine the impact of food assistance on this important out-
come. Although this paper does not investigate ART
adherence as an outcome, the role of food assistance pro-
grams in enabling successful ART programming cannot
be ruled out. At the household level, other potential ben-
efits of food assistance might include improved house-
hold food security, nutritional status of children,
providing a cushion for other household expenses such as
medication, school fees etc.
Like other health data systems in sub-Saharan Africa,
the TASO electronic data system does face the challenges
of completeness and accuracy of data elements (see for
example, [21]). Despite the short-comings noted above
related to missing data elements for the critical variables
of weight and WHO staging, among others, we contend
that the TASO data allow plausible inferences that are
central to the understanding of the role of food support
and nutrition to the health outcomes of people in treat-
ment for HIV and AIDS. As others have noted, many
important questions in the area of evidenced-based
nutrition or health policy cannot be answered easily with
randomized controlled trials [22,23]. The TASO data has
the attribute of generalizability because it reflects the
impacts of food support, using a widely implemented
program model, on health outcomes for a person not in a
carefully regulated and monitored clinical trial, but
among individuals receiving the day-to-day standard of
care of an indigenous NGO. Additionally, the TASO data
shed light on the role of food support in HIV and AIDS
care, a phenomenon which is extremely difficult to imag-
ine designing a randomized clinical trial because of ethi-
cal issues, but where observational data may allow
inferences to be constructed given naturally (quasi-exper-
imental) occurring variation. For these reasons, the
TASO data, despite their limitations, offer a unique
source of information concerning food support and HIV
and AIDS health outcomes.
Conclusions
Despite the limitations of our study, through construction
of a plausible control group and rigorous analysis of pro-
gram data, our finding of positive impacts of nutritional
support to HIV-infected individuals in a resource-limited
setting makes an important contribution to the evidence
of the benefit of food assistance programs. These findings
are highly relevant to program implementers. Further
carefully designed prospective studies evaluating the
impact of nutrition interventions employing experimen-
tal designs (where feasible) or thoughtful and rigorous
quasi-experimental designs, to improve health, nutrition
and quality of life outcomes among HIV-infected individ-
uals are critically needed. Donor agencies providing food
assistance integrated with HIV care and treatment pro-
grams should prioritize the need for such research.
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